This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Janus Kinase 2
|
Academic Article
|
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
|
Academic Article
|
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).
|
Academic Article
|
Beyond JAK inhibitor therapy in myelofibrosis.
|
Academic Article
|
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
|
Academic Article
|
Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies.
|
Academic Article
|
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis.
|
Academic Article
|
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
|
Academic Article
|
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.
|
Concept
|
Janus Kinase Inhibitors
|